DGX - Quest Diagnostics Incorporated

NYSE - NYSE Delayed Price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
9,883,000
9,883,000
10,788,000
9,437,000
7,726,000
Cost of revenue
6,450,000
6,450,000
6,579,000
5,804,000
5,037,000
Gross profit
3,433,000
3,433,000
4,209,000
3,633,000
2,689,000
Operating expenses
Selling general and administrative
1,874,000
1,874,000
1,727,000
1,550,000
1,457,000
Total operating expenses
2,005,000
2,005,000
1,828,000
1,662,000
1,458,000
Operating income or loss
1,428,000
1,428,000
2,381,000
1,971,000
1,231,000
Interest expense
148,000
138,000
151,000
163,000
175,000
Total other income/expenses net
-55,000
-55,000
369,000
76,000
20,000
Income before tax
1,235,000
1,235,000
2,599,000
1,884,000
1,076,000
Income tax expense
264,000
264,000
597,000
460,000
247,000
Income from continuing operations
1,015,000
1,015,000
2,080,000
1,499,000
886,000
Net income
946,000
946,000
1,995,000
1,431,000
858,000
Net income available to common shareholders
942,000
942,000
1,988,000
1,425,000
858,000
Basic EPS
-
8.10
15.85
10.62
6.36
Diluted EPS
-
7.97
15.55
10.47
6.28
Basic average shares
-
116,000
125,000
134,000
268,000
Diluted average shares
-
118,000
128,000
136,000
272,000
EBITDA
-
1,810,000
3,158,000
2,408,000
1,580,000